Tumor-specific gene expression in hepatic metastases by a replication-activated adenovirus vector

Area of Science:

• Oncology
• Gene Therapy
• Virology

Background:

• Clinical tumor gene therapy needs precise targeting to boost efficacy and reduce side effects.
• Current methods often lack exclusive tumor cell expression, leading to off-target effects.

Purpose of the Study:

• To demonstrate tumor-specific transgene expression in hepatic metastases using a modified adenovirus vector (AdE1-).
• To establish a novel gene expression system based on selective viral DNA replication in tumor cells.

Main Methods:

• Systemic administration of a modified first-generation (E1A/E1B-deleted) adenovirus vector (AdE1-) in mouse tumor models.
• Utilizing homologous recombination within the viral genome, triggered by viral DNA replication specific to tumor cells, to activate transgene expression.
• Employing mouse models with liver metastases derived from human tumor cells.

Main Results:

• Transgene expression was exclusively observed in all hepatic metastases after systemic vector application.
• No transgene induction was detected in normal liver tissue, indicating high tumor specificity.
• The AdE1- vector system demonstrated precise genomic rearrangements leading to functional expression cassettes.

Conclusions:

• A new concept for tumor-specific gene expression has been developed using replication-competent adenovirus vectors.
• This approach offers a promising strategy for enhancing the safety and efficacy of gene therapy for liver metastases.
• The vector system's tumor-specific activation mechanism is potentially applicable to other conditionally replicating adenovirus vectors.